Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vargas, F. S.
Right arrow Articles by Light, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vargas, F. S.
Right arrow Articles by Light, R. W.
(Chest. 2001;119:1516-1520.)
© 2001 American College of Chest Physicians

Experimental Pleurodesis in Rabbits Induced by Silver Nitrate or Talc*

1-Year Follow-up

Francisco S. Vargas, MD, FCCP; Lisete R. Teixeira, MD; Leila Antonangelo, MD; Marcelo A. C. Vaz, MD; Alipio O. Carmo, PharmD; Evaldo Marchi, MD and Richard W. Light, MD, FCCP

* From the Laboratory of Pleura (Drs. Vargas, Teixeira, Antonangelo, Vaz, Carmo, and Marchi), Division of Respiratory Diseases, Heart Institute (InCor), University of São Paulo Medical School, Brazil; and Department of Medicine of Saint Thomas Hospital and Vanderbilt University (Dr. Light), Nashville, TN.

Correspondence to: Richard W. Light, MD, FCCP, Director of Pulmonary Disease Program, Saint Thomas Hospital, 4220 Harding Rd, Nashville, TN 37205; e-mail: rlight98{at}yahoo.com

Study objective: To compare the pleurodesis results from the intrapleural injection of silver nitrate and talc slurry over an observation period of 12 months in rabbits.

Design: Rabbits were randomized to receive 2 mL of 0.5% silver nitrate or 400 mg/kg of talc slurry in 2 mL intrapleurally. Ten rabbits in each group were killed at 1 month, 2 months, 4 months, 6 months, 8 months, 10 months, and 12 months after intrapleural injection. The degree of gross pleurodesis and the amount of microscopic pleural fibrosis and inflammation were graded on a scale of 0 to 4.

Results: The mean ± SEM gross pleurodesis score in the 70 rabbits that received silver nitrate was 3.34 ± 0.08, which was significantly higher than the score of 2.32 ± 0.09 in the 70 rabbits that received talc. The mean gross pleurodesis score was significantly higher at each of the observation times (p < 0.05), except at 2 months, in the rabbits that received silver nitrate. The pleurodesis was distributed throughout the thorax in the rabbits that received silver nitrate, while it was only in the ventral thorax in the rabbits that received talc slurry. The gross pleurodesis scores showed no tendency to decrease during the 12-month observation period in either treatment group. The persistence of talc in the pleural space did not lead to chronic inflammatory changes because the inflammation scores were similar in both groups at all observation times. The microscopic pleural fibrosis score tended to decrease with time in the silver nitrate group but not in the talc slurry group.

Conclusions: The intrapleural injection of 2 mL of 0.5% silver nitrate produces a better pleurodesis than does the intrapleural injection of 400 mg/kg of talc slurry in rabbits. The pleurodesis induced by silver nitrate persists for at least 1 year. The efficacy of silver nitrate as a sclerosing agent in humans should be evaluated.

Key Words: pleural effusion • pleurodesis • pneumothorax • silver nitrate • talc




This article has been cited by other articles:


Home page
ChestHome page
L. R. Teixeira, F. S. Vargas, M. M. P. Acencio, P. F. S. Paz, L. Antonangelo, M. A. C. Vaz, and E. Marchi
Influence of Antiinflammatory Drugs (Methylprednisolone and Diclofenac Sodium) on Experimental Pleurodesis Induced by Silver Nitrate or Talc
Chest, December 1, 2005; 128(6): 4041 - 4045.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Marchi, F. S. Vargas, L. R. Teixeira, M. M. P. Acencio, L. Antonangelo, and R. W. Light
Intrapleural Low-Dose Silver Nitrate Elicits More Pleural Inflammation and Less Systemic Inflammation Than Low-Dose Talc
Chest, September 1, 2005; 128(3): 1798 - 1804.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Marchi, F. S. Vargas, M. M. P. Acencio, L. Antonangelo, L. R. Teixeira, E. H. Genofre, and R. W. Light
Talc and Silver Nitrate Induce Systemic Inflammatory Effects During the Acute Phase of Experimental Pleurodesis in Rabbits
Chest, June 1, 2004; 125(6): 2268 - 2277.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Sartori, D. Tassinari, P. Ceccotti, P. Tombesi, I. Nielsen, L. Trevisani, and V. Abbasciano
Prospective Randomized Trial of Intrapleural Bleomycin Versus Interferon Alfa-2b via Ultrasound-Guided Small-Bore Chest Tube in the Palliative Treatment of Malignant Pleural Effusions
J. Clin. Oncol., April 1, 2004; 22(7): 1228 - 1233.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Marchi, L. R. Teixeira, F. Vargas, P. Astoul, A. Fraticelli, A. Robaglia-Schlupp, and P. Cau
Talc for Pleurodesis: Hero or Villain?
Chest, July 1, 2003; 124(1): 416 - 417.
[Full Text] [PDF]


Home page
ChestHome page
R. W. Light
Talc for Pleurodesis?
Chest, November 1, 2002; 122(5): 1506 - 1508.
[Full Text] [PDF]


Home page
ChestHome page
C. A. Olivares-Torres, R. Laniado-Laborin, C. Chavez-Garcia, C. Leon-Gastelum, A. Reyes-Escamilla, and R. W. Light
Iodopovidone Pleurodesis for Recurrent Pleural Effusions*
Chest, August 1, 2002; 122(2): 581 - 583.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.